O	0	6	Canine
B-Protein	7	13	COL1A2
O	14	22	mutation
O	23	32	resulting
O	33	35	in
O	36	37	C
O	37	38	-
O	38	46	terminal
O	47	57	truncation
O	58	60	of
O	61	64	pro
O	64	65	-
O	65	71	alpha2
O	71	72	(
O	72	73	I
O	73	74	)
O	75	78	and
O	79	85	severe
O	86	98	osteogenesis
O	99	109	imperfecta
O	109	110	.

O	112	115	RNA
O	116	119	and
O	120	124	type
O	125	126	I
O	127	135	collagen
O	136	140	were
O	141	149	analyzed
O	150	154	from
O	155	163	cultured
O	164	168	skin
O	169	180	fibroblasts
O	181	183	of
O	184	185	a
O	186	192	Beagle
O	193	198	puppy
O	199	203	with
O	204	213	fractures
O	214	224	consistent
O	225	229	with
O	230	234	type
O	235	238	III
O	239	251	osteogenesis
O	252	262	imperfecta
O	263	264	(
O	264	266	OI
O	266	267	)
O	267	268	.

O	269	271	In
O	272	273	a
O	274	285	nonisotopic
O	286	291	RNAse
O	292	300	cleavage
O	301	306	assay
O	307	308	(
O	308	313	NIRCA
O	313	314	)
O	314	315	,
O	316	319	the
O	320	327	proband
O	327	328	'
O	328	329	s
O	330	333	RNA
O	334	337	had
O	338	339	a
O	340	346	unique
O	347	355	cleavage
O	356	363	pattern
O	364	366	in
O	367	370	the
O	371	377	region
O	378	380	of
B-Protein	381	387	COL1A2
O	388	396	encoding
O	397	400	the
B-Protein	401	402	C
I-Protein	402	403	-
I-Protein	403	413	propeptide
O	413	414	.

O	415	418	DNA
O	419	427	sequence
O	428	436	analyses
O	437	447	identified
O	448	449	a
O	450	458	mutation
O	459	461	in
O	462	467	which
O	468	479	nucleotides
O	480	484	3991
O	484	485	-
O	485	489	3994
O	490	491	(
O	491	492	"
O	492	496	CTAG
O	496	497	"
O	497	498	)
O	499	503	were
O	504	512	replaced
O	513	517	with
O	518	519	"
O	519	528	TGTCATTGG
O	528	529	.
O	529	530	"
O	531	534	The
O	535	540	first
O	541	546	seven
O	547	552	bases
O	553	555	of
O	556	559	the
O	560	568	inserted
O	569	577	sequence
O	578	582	were
O	583	592	identical
O	593	595	to
O	596	607	nucleotides
O	608	612	4002
O	612	613	-
O	613	617	4008
O	618	620	of
O	621	624	the
O	625	631	normal
O	632	638	canine
B-Protein	639	645	COL1A2
O	646	654	sequence
O	654	655	.

O	656	659	The
O	660	669	resulting
O	670	680	frameshift
O	681	688	changed
O	689	691	30
O	692	697	amino
O	698	703	acids
O	704	707	and
O	708	718	introduced
O	719	720	a
O	721	730	premature
O	731	735	stop
O	736	741	codon
O	741	742	.

O	743	750	Reverse
O	750	751	-
O	751	764	transcription
O	765	775	polymerase
O	776	781	chain
O	782	790	reaction
O	791	792	(
O	792	794	RT
O	794	795	-
O	795	798	PCR
O	798	799	)
O	800	804	with
O	805	812	primers
O	813	821	flanking
O	822	825	the
O	826	834	mutation
O	835	839	site
O	840	849	amplified
O	850	853	two
O	854	867	complementary
O	868	871	DNA
O	872	873	(
O	873	877	cDNA
O	877	878	)
O	879	888	fragments
O	889	892	for
O	893	896	the
O	897	904	proband
O	905	908	and
O	909	910	a
O	911	917	single
O	918	925	product
O	926	929	for
O	930	933	the
O	934	941	control
O	941	942	.

O	943	954	Restriction
O	955	961	enzyme
O	962	972	digestions
O	973	977	also
O	978	982	were
O	983	993	consistent
O	994	998	with
O	999	1000	a
O	1001	1013	heterozygous
O	1014	1022	mutation
O	1023	1025	in
O	1026	1029	the
O	1030	1037	proband
O	1037	1038	.

O	1039	1043	Type
O	1044	1045	I
O	1046	1057	procollagen
O	1058	1065	labeled
O	1066	1070	with
O	1071	1072	[
O	1072	1074	3H
O	1074	1075	]
O	1075	1082	proline
O	1083	1086	was
O	1087	1095	analyzed
O	1096	1098	by
O	1099	1105	sodium
O	1106	1113	dodecyl
O	1114	1121	sulfate
O	1121	1122	-
O	1122	1136	polyacrylamide
O	1137	1140	gel
O	1141	1156	electrophoresis
O	1157	1158	(
O	1158	1161	SDS
O	1161	1162	-
O	1162	1166	PAGE
O	1166	1167	)
O	1167	1168	.

O	1169	1178	Increased
O	1179	1186	density
O	1187	1189	of
B-Protein	1190	1192	pC
I-Protein	1192	1193	-
I-Protein	1193	1199	alpha2
I-Protein	1199	1200	(
I-Protein	1200	1201	I
I-Protein	1201	1202	)
O	1203	1212	suggested
O	1213	1224	comigration
O	1225	1229	with
O	1230	1233	the
O	1234	1243	similarly
O	1244	1249	sized
O	1250	1253	pro
O	1253	1254	-
B-Protein	1254	1260	alpha2
I-Protein	1260	1261	(
I-Protein	1261	1262	I
I-Protein	1262	1263	)
O	1264	1271	derived
O	1272	1276	from
O	1277	1280	the
O	1281	1287	mutant
O	1288	1294	allele
O	1294	1295	.

O	1296	1307	Furthermore
O	1307	1308	,
O	1309	1310	a
O	1310	1311	-
O	1311	1317	chains
O	1318	1322	were
B-Hydroxylation	1323	1339	overhydroxylated
O	1340	1343	and
O	1344	1347	the
O	1348	1353	ratio
O	1354	1356	of
B-Protein	1357	1363	alpha1
I-Protein	1363	1364	(
I-Protein	1364	1365	I
I-Protein	1365	1366	)
O	1366	1367	:
B-Protein	1367	1373	alpha2
I-Protein	1373	1374	(
I-Protein	1374	1375	I
I-Protein	1375	1376	)
O	1377	1380	was
O	1381	1382	3
O	1382	1383	.
O	1383	1384	2
O	1384	1385	:
O	1385	1386	1
O	1386	1387	,
O	1388	1398	consistent
O	1399	1403	with
O	1404	1407	the
O	1408	1416	presence
O	1417	1419	of
B-Protein	1420	1426	alpha1
I-Protein	1426	1427	(
I-Protein	1427	1428	I
I-Protein	1428	1429	)
O	1430	1441	homotrimers
O	1441	1442	.

O	1443	1451	Analyses
O	1452	1454	of
B-Protein	1455	1461	COL1A2
O	1462	1465	and
O	1466	1470	type
O	1471	1472	I
O	1473	1481	collagen
O	1482	1486	were
O	1487	1491	both
O	1492	1502	consistent
O	1503	1507	with
O	1508	1511	the
O	1512	1521	described
O	1522	1534	heterozygous
O	1535	1543	mutation
O	1544	1553	affecting
O	1554	1557	the
O	1558	1561	pro
O	1561	1562	-
B-Protein	1562	1568	alpha2
I-Protein	1568	1569	(
I-Protein	1569	1570	I
I-Protein	1570	1571	)
O	1572	1573	C
O	1573	1574	-
O	1574	1584	propeptide
O	1585	1588	and
O	1589	1598	confirmed
O	1599	1600	a
O	1601	1610	diagnosis
O	1611	1613	of
O	1614	1616	OI
O	1616	1617	.
